Disitamab Vedotin Combined with Apatinib in Gastric Cancer: A Case Report and Review of Literature
WORLD JOURNAL OF CLINICAL ONCOLOGY（2024）
Key words
Human epidermal growth factor receptor 2-positive gastric cancer,RC48,Apatinib,Combination therapy,Progression-free survival,Case report
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined